PlumX Metrics
Embed PlumX Metrics

Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors

JAMA Oncology, ISSN: 2374-2445, Vol: 5, Issue: 4, Page: 489-490
2019
  • 1
    Citations
  • 0
    Usage
  • 12
    Captures
  • 2
    Mentions
  • 22
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    1
  • Captures
    12
  • Mentions
    2
    • News Mentions
      2
      • News
        2
  • Social Media
    22
    • Shares, Likes & Comments
      22
      • Facebook
        22

Most Recent News

Meta-analysis: Combo therapies best for neuroendocrine tumors

Commentary: One question that remains from the study by Reto M. Kaderli, MD, and his colleagues is the comparative advantages and disadvantages of the various

Article Description

JAMA Oncology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know